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Food allergy in mice is modulated 
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pathway
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Abstract 
Background: Thymic stromal lymphopoietin (TSLP) is involved in the pathogenesis of allergic reactions in the skin 
and the lung. Nevertheless, data on the role of TSLP in food allergy are scarce. We explored the role of TSLP in a mouse 
model with oral sensitization and oral challenge eliciting food allergy.
Methods: TSLP receptor (TSLPR)−/− mice and wild type mice were orally sensitized to β-lactoglobulin in presence 
of cholera toxin (CT) or CT alone. The elicited immune response was characterized in vitro and the mice were sub-
sequently challenged with the antigen. Lymphocytes from various locations in the gut were activated either by the 
antigen or by CT and assayed for cytokine secretion.
Results: Here we report that TSLPR−/− are less prone to generate food-induced reactions in conjunction with a 
decreased antigen-specific IgG1, but not IgE response. In addition, mesenteric lymphnode lymphocytes of TSLPR−/− 
mice were secreting lower quantities of IL-4, IL-5 and IL-10 after in vivo Ag activation, whereas higher numbers of IL-17 
secreting cells were observed. Similarly, activation by the Th2-type adjuvant cholera toxin resulted in an increased 
frequency of IL-12 and IL-17 secreting lamina propria and mesenteric lymphocytes, together with increased produc-
tion of IL-12 by activated dendritic cells in TSLPR−/− mice.
Conclusions: TSLP can be considered as an essential, but not exclusive, mediator for elicitation of food allergy in 
mice, as well as a potential target for future therapeutic interventions.
© 2016 Frossard et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The pathogenesis of food allergy involves various mecha-
nisms, all closely associated with the gut-related immune 
system [1]. Initiation of IgE-mediated food allergy follows 
the path of Th2-type sensitization involving antigen pres-
entation and CD4+  T cells, followed by IL-4 and IL-13 
facilitated antigen-specific IgE production. Mice models 
of food allergy with oral sensitization to common food 
antigens eliciting anaphylactic reactions upon re-expo-
sure have allowed extensive description of Th2-type, gut-
related mechanisms of IgE-mediated food allergy [2, 3]. 
In addition to IgE-dependent pathways of gut-mediated 
anaphylaxis, other mechanistic pathways have been 
described, e.g. by involving IgG1 antibodies, or antigen-
activated complement [4, 5]. Thymic stromal lymphopoi-
etin (TSLP) dependant mechanisms of food allergy have 
also been suspected [6, 7].
TSLP has a close four helix structural analogy to IL-7, 
and can be found secreted in increased amounts in epi-
thelial cells (EC) of the skin, the lung and the gut. TSLP 
is expressed in presence of the Th2–type cytokines IL-4 
and IL-13 [8–13]. TSLP in relation to allergy has been 
first studied in atopic dermatitis where increased levels 
have been found in inflamed skin associated with Th2-
type cytokines [14]. Similarly, TSLP receptor (TSLPR)−/− 
mice lacking responsiveness to TSLP fail to express 
Th2-type cytokines and lung inflammation [15, 16]. It has 
also been demonstrated that skin-derived dendritic cells 
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the skin [17]. In the gut, intestinal EC produce TSLP, and 
expression of TSLP and the TSLPR are closely linked to 
inflammation mediated by IL-12, IL-17, and Th2-type 
cytokines [18, 19].
We hypothesize that, similarly to the skin and the lung, 
IgE-mediated immunity in the gut is regulated by TSLP 
and its receptor. For these studies, we used a well char-
acterized mouse model with oral antigen sensitized with 
β-lactoglobulin (BLG) in presence of the Th2-type adju-
vant cholera-toxin (CT). The main characteristic of this 
widely used model are symptoms of anaphylaxis upon 
food gavage [20, 21], the most closely reproducing symp-
toms seen in food allergy in humans. Clinical param-
eters and biomarkers were measured in wild-type (wt) 
and TSLPR−/− mice in the light of two specific aims: 
(1) to investigate if a functional TSLPR was instrumen-
tal in eliciting food allergy, and (2) to assess the role of 




BALB/c female mice were purchased from Charles River 
(L’Arbresle, France) and were housed at the Animal Facil-
ities of the University of Geneva, School of Medicine. 
TSLPR−/− mice [22] were backcrossed to a BALB/c 
background for eight generations or more. All animals 
were used between 4 and 5  weeks of age and were fed 
with standard mice pellets without milk proteins. All 
experiments were approved by the Animal Studies Eth-
ics Committee and performed in accordance to their 
guidelines.
Antibodies, reagents and medium
Anti-CD11c (HL3), anti-IL-4 (11B11), anti-IL-5 (TRFK5), 
anti-IL-10 (JES5-16E3), anti-IL-12p70 (C15.6) and anti-
IL-17 (TC11-18H10) were from BD Pharmingen (Alls-
chwil, Switzerland). Anti-IL-13 was from eBioscience 
(eBio13A) (Vienna, Austria).
CT was from List Biological Labs (Campbell, CA, 
USA). BLG was from Sigma (Buchs, Switzerland).
RPMI 1640 and DMEM medium were supplemented 
with 100 U/ml penicillin, 100  µg/ml streptomycin, 
2  mM  l-glutamine, 100  μg/ml gentamicin, 15  mM 
HEPES pH 7.4 and 10  % heat-inactivated FCS. In addi-
tion, DMEM was supplemented 2  ×  10−5  M 2-mer-
captoethanol, 1  % nonessential amino acids and 1  mM 
sodium pyruvate (all reagents from Sigma).
In vivo sensitization, and BLG specific challenge
Mice were sensitized 5 times 1 week apart by oral admin-
istration of 10  µg of CT in association with 10  mg of 
antigen in a solution containing 0.2 M of NaHCO3, pH 9. 
An oral antigen challenge was performed 1 week after the 
last sensitization by gavaging 100 mg BLG. A score based 
on symptoms of anaphylaxis (0 no reaction; 1 mild reac-
tions: decreased activity, random scratching, myocloni; 2 
moderate reactions: marked decreased activity, continu-
ous scratching, abnormal breathing; 3 severe reactions 
low or absence of reactivity, abnormal breathing leading 
occasional to death) was assessed [21]. Mice were there-
after sacrificed at the indicated time and their intestinal 
lymphoid cells isolated.
Measurement of BLG‑specific antibodies in mouse serum
Sera were obtained 7 days after the last sensitization by 
tail vein bleeding. BLG-specific Ab titers were measured 
by a method adapted from Adel-Patient et  al. [23] as 
described previously [24].
Isolation of lymphocytes
After sacrifice of the mice with CO2, mesenteric lymph 
nodes (MLN) were isolated, the small intestine was 
excised, and Peyer’s patches (PP) lymphocytes, lamina 
propria lymphocytes (LPL), intraepithelial lymphocytes 
(IEL) and epithelial cells (EC) were isolated using modi-
fied methods as previously described [25, 26]. Briefly, the 
small intestine was opened longitudinally and cut into 
5-mm pieces. The tissue was incubated in calcium- and 
magnesium-free cHBSS containing 2  mM EDTA and 
1  mM dithiothreitol (Sigma) for 30  min at 37  °C with 
magnetic stirring. It was then vigorously vortexed and 
filtered through a 70-μm nylon filter in order to obtain 
a cell suspension. The cell population was washed twice 
and separated by discontinuous 33/40  % Percoll (Bio-
science, Uppsala, Sweden) on a lympholyte M gradient 
(Cederlane, Hornby, Canada) for 20 min at 600 g at room 
temperature. IELs were harvested on the Percoll 40  % 
lympholyte M interface, and ECs on the 30 % interface.
Cytokine measurement by ELISPOT
ELISPOT plates were coated with streptavidin overnight 
at 37 °C, followed by addition of 1 μg of biotinylated BLG 
for 3 h. Lymphocytes isolated on a Percoll 60/66 % gradi-
ent (Amersham, Zurich, Switzerland) were resuspended 
as 2 and 1 ×  106 in Iscove’s modified Dulbeco medium 
supplemented with penicillin, streptomycin, l-glutamine, 
100 μg/mL gentamycin, polymixin B + 5 % FCS for 24 h 
at 37  °C, followed by overnight incubation at 4  °C with 
the corresponding antibodies. Amino-ethyl-carbazole 
100 μl/well was added for 10  min, and the spots were 
automatically counted by the KS EliSpot 4.2.1 Software 
(Zeiss, Halbermoos, Germany) and expressed as cell 
forming units (CFU) per 106 cells.
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Real‑time PCR
Total RNA from PP lymphocytes, LPL, IEL or EC was 
extracted with Isol-RNA Lysis reagent. 5 x 106 cells 
were first centrifuged 5  min at 1400×g and the pellet 
was resuspended in 1.0  ml of Isol-RNA Lysis reagent 
for 5 min., 0.2 ml chloroform was added and tubes were 
mixed by inversion for 30  s and left for 3  min at room 
temperature. Samples were then centrifuged for 15  min 
at 14,000 rpm (4 °C) resulting in a colorless upper aque-
ous phase that contains the RNA and a lower red organic 
phase. 0.5 ml isopropyl alcohol was added to the aqueous 
phase in order to precipitate RNA. After centrifugation, 
the RNA pellet was washed once in 1 ml 75 % ethanol. At 
the end of the procedure, the RNA pellet was briefly air-
dried and resuspended in 40 μl RNAse-free water.
RNA content of each sample was assessed using a nan-
odrop ND-1000 spectophotometer. 1 µg of RNA was used 
to perform the semi-quantitative RT-PCR with specific 
primers for the mouse TSLP gene. The PCR was real-
ized [using taq DNA polymerase from Invitrogen (Zug, 
Switzerland)], with the following primers: 5′-GACAG-
CATGGTTCTTCTCAG-3′ and 5′-CTGGAGATTGA-
CATGAAGG-3′ (30 cycles of 94 °C for 60 s denaturation, 
55 °C for 60 s annealing, and 72 °C for 60 s extension). As 
a control, the same amount of RNA was used to perform 
a semi-quantitative RT-PCR with specific primers for 
GAPDH. The final result was expressed as the ratio of the 
signal obtained for TSLP divided by the signal obtained 
for GAPDH.
Statistics analysis
Statistical significance between groups was analyzed 
by using the Wilcoxon rank-sum test for nonparamet-
ric unpaired data. For assessment of clinical reactivity, 
batches of 4–5 mice were challenged simultaneously, and 
the experiments were repeated twice. Antibody titers 
measurements and cell experiments were performed 
with pooled samples from three mice per experiments, 
and repeated 3 times.
Results
TSLPR−/− mice have less pronounced food allergy 
symptoms
In order to generate mice with an allergic phenotype 
to foods, sets of mice were sensitized 5 times at 1 week 
interval by intra-gastric gavage with BLG in presence of 
CT. Allergy was characterized by mean of a subsequent 
oral BLG challenge. Mice were clinically evaluated by a 
symptom score published earlier [21]. In order to add an 
objective measure, the severity of anaphylaxis was cor-
related to the measure of decreased body temperature. 
We observed that wt mice were showing symptoms of 
anaphylaxis in form of decreased activity, swelling of the 
snout, erythema of the face and feet, as well as itching 
and erected pilli. Increased breathing and severe reac-
tions leading to death were also observed. In correlation 
to these observations, marked decreased body tempera-
ture was seen, peaking at 30  min after gavage (Fig.  1a). 
Conversely, assessment of TSLPR−/− mice at the same 
time points showed predominantly mild or no symptoms 
of anaphylaxis (Fig.  1b) and a faster recovery correlat-
ing to only a slight decrease in body temperature. These 
results suggest that food-mediated allergic reactions are, 
to a significant extent, mediated by a TSLP-dependent 
mechanism.
How do antigen‑specific serum antibody levels correlate 
with TSLP?
We were then interested in characterizing BLG-specific 
antibody production in wt, and TSLPR−/− mice. Serum 
was collected 7 days after the last oral antigen-sensitiza-
tion and BLG-specific IgE (Fig.  2a), IgG1 (Fig.  2b) and 
IgG2a (Fig. 2c) antibody titers were measured by ELISA. 
Clearly, wt mice had much higher titers of IgG1 (in wt 
mice: mean 51.0  ±  9.4 AU/ml, TSLPR−/− mice: mean 
16.0 ± 2.7 AU/ml), a Th2-type related antibody isotype, 
while IgG2a, a Th1-type related isotype was increased in 
TSLPR−/− mice. IgE titers were similar in both groups.
Is the modulation of Th2‑type cytokine secretion 
after in vivo antigen‑specific cell activation TSLPR 
dependent?
In order to correlate cytokine production and TSLP 
expression after sensitization to BLG, we isolated 
MLN cells 8  h after infra-clinical antigen gavage given 
for in  vivo cell activation and measured their ex  vivo 
cytokine production by ELISPOT. The presence of the 
TSLPR was clearly modulating cytokine production, as 
shown by a decreased secretion of IL-4, IL-5 and IL-10 
in TSLPR−/− mice (79  % decrease of IL-4 secretion, 
80 % of IL-5, 51 % of IL-10; significant for IL-4 and IL-5 
but only trend for IL-10) (Fig.  3). In contrast, we did 
measure strongly increased levels of IL-17 (4.4 times) 
in TSLPR−/− mice. IL-12 (not shown) was secreted in 
similar amounts by MLN cells isolated from both type of 
mice.
CT activates TSLP in gut epithelial cells
We next investigated whether TSLP RNA expression was 
related to the CT administration given by gavage during 
the sensitization. RNA expression of TSLP by gut EC, 
Peyer’s patches cells, lamina propria lymphocytes and 
intra-epithelial lymphocytes from wt mice was measured 
by semi-quantitative RT-PCR at various time points after 
CT administration. Only EC (other cells not shown) were 
found to express TSLP RNA after administration of CT 
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(Fig.  4a). Figure  4b shows the progressively increased 
expression of TSLP RNA with a peak at 48  h post CT 
administration, clearly showing a CT-related TSLP RNA 
expression in gut EC of wt mice.
Does the TSLPR regulate CT‑induced inflammation in the 
gut?
Next we explored if and to what extent, the TSLPR was 
regulating CT-induced inflammation. By ELISPOT, 
we measured ex  vivo CT-induced cytokine produc-
tion of mesenteric lymph node (MLN) cells and lamina 
propria cells (LPL) from wt and TSLPR−/− mice after 
oral gavage with CT. Figure 5 shows a clear modulation 
of IL-12 secretion by TSLP in both MLN and LPL as 
IL-12 is increased in TSLPR−/− mice (MLN cells in 
wt mice: mean 38.6  ±  14.9 spots/106 cells, TSLPR−/− 
mice: mean 137.8 ± 4.9 spots/106 cells; LPL in wt mice: 
mean 12.2 ± 8.3 spots/106 cells, TSLPR−/− mice: mean 
45.7  ±  15.3 spots/106 cells). Similarly, IL-17 expression 
was strongly increased in TSLPR−/− mice (MLN in 
wt mice: mean 62.8  ±  13.4 spots/106 cells, TSLPR−/− 
mice: mean 156.9 ± 16.5 spots/106 cells; LPL in wt mice: 
mean 20.5 ± 2.9 spots/106 cells, TSLPR−/− mice: mean 
47.0 ± 18.8 spots/106 cells). IL-13 secretion was strongly 
decreased in TSLPR−/− mice, but only in LPL. IL-10 
secretion was not influenced by the absence of expression 
Fig. 1 Reduced severity of anaphylactic reaction in CT-sensitized TSLPR−/− mice. BLG-sensitized mice, either wild type (wt) and TSLPR−/− mice 
(ko) are challenged by oral gavage with 100 mg of BLG 7 days after the last sensitization, the body temperature is recorded on the ear (a). In 
addition symptoms of anaphylaxis were clinically assessed (0 no reaction to 3 severe reaction) (b). The results are expressed as a pool of data from 
independent experiments. *p < 0.05
Fig. 2 Th2-related and Th1-related Ab profiles in BLG-sensitized wild type and TSLPR−/− mice. Serum IgE (a), IgG1 (b) and IgG2a (c) Abs specific 
for BLG in BLG-sensitized wild type (wt) and TSLPR−/− mice (ko) 7 days after the last sensitization. The results are expressed as arbitrary units from 
three independent experiments. *p < 0.05
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of the TSLP receptor. These results are suggesting that 
IL-12 and IL-17-driven inflammation in the current 
model is regulated by TSLP in the gut.
Discussion
Experiments presented here clearly show that food 
allergy in mice induced after oral antigen sensitization in 
presence of CT followed by an oral antigen challenge is 
strongly, but not exclusively, dependent on a functional 
TSLP pathway. Absence of TSLP receptor expression 
in knock-out mice biases antigen and CT sensitization 
towards a reduced Th2/increased Th17-type profile, and 
influences dendritic cells to promote a Th1-type antigen 
presentation. TSLP can be considered as a protein con-
tributing to modulating food allergy in the mouse model 
described here.
The pathogenesis of immediate-type food allergy is 
strongly Th2-type oriented with subsequent IgE pro-
duction and IgE-mediated immediate-type symptoms. 
We and others have previously described that intestinal 
T cells produce Th2-type cytokines, and that the gut-
associated lymphoid structures are strongly involved 
in the pathogenesis of the disease [2, 3]. Nevertheless, 
IgE-independent mechanisms have also been described, 
involving IgG antibody isotype or complement-driven 
inflammation [4, 5]. TSLP in the context of allergy has 
so far been more extensively studied in atopic dermati-
tis and asthma. In these diseases, it has been shown that 
in the skin TSLP is essential for eliciting a Th2-type skin 
sensitivity, as TSLPR−/− mice were unable to mount a 
Th2-type cytokine production, with the resulting absence 
of antigen-specific IgE production, and of skin inflam-
mation upon re-exposure to the antigen [17]. In the 
experiments we report here, we were able to show simi-
lar results in the gut. We observed that not only TSLP 
is essential for the secretion of the Th2-type cytokines 
IL-4 and IL-5, but also that the Th1 and Th17 pathways 
are TSLP dependent, as IL-12 and IL-17 were strongly 
increased in TSLPR−/− mice. These results are in line 
with previous publications which have shown increased 
Th1 and Th17 responses in TSLPR−/− mice [18, 19]. In 
this regard, we have not seen a modified IgE response in 
TSLPR−/− mice, while IgG1 was significantly lower in 
TSLPR−/− mice. This finding is correlated to previous 
studies reporting that in mice mechanisms independ-
ent of IgE might be involved in the pathogenesis of food 
allergy [27], and suggests that TSLP might be linked to 
them. It is also well known in humans that sensitization 
to IgE might appear independently of clinical food allergy 
[28].
Gut intraepithelial lymphocytes constitutively express 
IL-17 [26], and it has been clearly shown that this 
cytokine is involved in inflammation in the gut. In addi-
tion, it has been shown that TSLP expression and IL-
17A is linked, as disruption of the TSLP-TSLPR pathway 
Fig. 3 Reduced Th2 cytokines and increase of IL-17 in BLG-sensitized 
TSLPR−/− mice by ELISPOT. Ex vivo cytokines secretion by mesen-
teric lymphnode lymphocytes 8 h after oral boost with 20 mg of BLG 
in NaHCO3 in wild type (wt) and TSLPR−/− (ko) mice. The results are 
expressed as number of cytokines forming spots/106 cells from three 
independent experiments. *p < 0.05
Fig. 4 CT induced expression of TSLP in vivo. a TSLPR expression in 
epithelial cells from wild type (WT), and TSLPR−/− mice (K.O.). The 
band representing TSLP is marked by an arrow. b Relative TSLP mRNA 
expression by intestinal epithelial cells from WT mice (close circles) 
and from K.O. mice (open circles) after oral administration of 10 mg of 
cholera toxin. The results (in %) are normalized to GAPDH expression
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resulted in increased expression of IL-17A, and the devel-
opment of severe gut inflammation [19]. In relation to 
food allergy, the study by DeLong et al. reports activation 
with the major peanut allergen Ara h 1 of T cell-lines and 
clones from peanut allergic subjects. While all cells pro-
duced IL-4, IL-17 secreting cells were also found. Inter-
estingly, the percentage of cells co-producing IL-4 and 
IL-17 was minimal, suggesting similarly to our study an 
antagonistic role for IL-4 and IL-17 [29]. Decreased IL-17 
secretion has also been observed in antigen-activated 
CD4+  cells from food allergic children when compared 
to tolerant controls [30]. This suggests that in humans, 
IL-17 may be involved to some extent in the regulation 
of food allergy. Similarly to food allergy, in eczema and 
asthma the paradigm of the dysbalance of Th1 and Th2 
cells has been completed by increased knowledge of the 
role of Th17, as well as other T cell sub-types [31].
The role of TSLP has been ascertained in the regula-
tion of various experimental types of allergy, e.g. in mod-
els of skin allergy, such as atopic dermatitis [32] or nickel 
allergy [33], or in allergic airway diseases [15, 16]. Simi-
lar observations have been made in human studies [14, 
34]. Several investigations addressed the role of TSLP in 
food allergy. Hong et al. have suspected a role for TSLP, 
as a specific single nucleotide polymorphism of the TSLP 
gene was correlated with an increased sensitization to 
common food allergens in correlation to breastfeeding 
[35]. Also, eosinophilic esophagitis, an inflammatory dis-
ease of the esophagus associated with food allergy char-
acterized by esophageal eosinophilia, has been associated 
with TSLP gene polymorphisms [36]. Links between the 
skin and the gut have also been explored. TSLP-asso-
ciated antigen sensitization through the skin has been 
shown to induce diarrhea and anaphylaxis after oral re-
exposure to the same antigen [37]. Also, TSLP has been 
found to modulate allergy through antigen exposure on 
the skin and subsequent allergic reactions similar to our 
model [6]. In the gut, TSLP is also produced by DCs, and 
protects against inflammatory colitis [38]. Exploring the 
role of TSLP in two separate murine food allergy models, 
Blazquez et al. have found that allergen-induced diarrhea 
was TSLPR dependent, while the Th2-type sensitiza-
tion model they used was TSLP independent with simi-
lar antigen-specific IgE titers, and absence of decreased 
anaphylaxis upon allergen reexposure [7]. However, in 
their studies mice were challenged by i.p. injections, 
while we gavaged them, this can possibly explain the dif-
ference in the antigen-induced anaphylaxis score. Also, 
Fig. 5 Increased frequency of IL-12 and IL-17 producing cells in CT-sensitized TSLPR−/− mice by ELISPOT. Ex vivo cytokine secretion by mesenteric 
lymphnode (MLN) or lamina propria (LPL) lymphocytes 24 h following oral gavage with 10 μg of CT in NaHCO3 in wild type (wt) and TSLPR−/− (ko) 
mice. The results are expressed as number of cytokines forming spots/106 cells from three independent experiments. *p < 0.05
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antigen-specific IgG1 titers were not measured, and an 
IgE-independent mechanism cannot be excluded. Chu 
et  al. have observed that after a similar oral sensitiza-
tion protocol than the one we used, but followed by an 
i.p. antigen challenge, the procedure elicited a similar 
anaphylactic response in TSLPR−/− mice than in wt 
mice [39]. In these studies, besides IgE IgG1 titers were 
measured and both were found similar in wild type and 
TSLPR−/− mice. The results in these two studies differ 
from ours.
Our results suggest that absence of a functional TSLP 
does only partially prevent food-induced sensitization, as 
TSLPR−/− mice are able to mount an antigen-specific 
Ab response. In addition, absence of functional TSLP 
does not prevent a response to the strong stimulus of 
i.p. food antigen challenge, while it significantly reduces 
the anaphylactic response after a more physiological gas-
tric antigen challenge. Altogether, these results suggest 
that TSLP, in addition to other factors, intervenes in the 
pathogenesis of food allergy in the mouse models studied 
here.
It has been well recognized that allergy in general and 
food allergy in particular is mediated by several, com-
plementary, but independent pathways. Options for 
treatment or prevention have targeted several of these 
pathways. In various studies, therapeutic options includ-
ing oral administration of IL-12 [40], oral administra-
tion of a synthetic agonist of Toll-like receptor 9 [41], 
or blockade of platelet-activating factor and histamine 
[42] have been investigated for treatment of food allergy. 
Recently, a preliminary trial in patients with allergen-
induced asthma and airway inflammation has found a 
therapeutic value for an anti-TSLP monoclonal immu-
noglobulin [43]. Here we define TSLP as a new target for 
modulation of food allergy. Indeed, we identified TSLP 
as an essential contributor to the pathogenesis of the 
Th2-type inflammation elicited after oral sensitization 
followed by an oral challenge. The immunological param-
eters correlated with a strong decrease of clinical reac-
tivity upon oral antigen challenge reinforcing a strong 
dependency of food allergy on TSLP. Defining whether 
this is due to a lack of direct control of TSLP on T cells or 
on DCs will need further exploration.
Conclusions
In conclusion, in the set of experiments presented here, 
we show that food allergy in mice is in part dependent 
on a functional TSLP receptor, as antigen sensitization in 
TSLPR−/− mice was biased towards an allergy protec-
tive, reduced Th2/increased Th17-type immune response 
with decreased clinical reactivity. New therapeutic strate-
gies might consider including TSLP as a target for modu-
lation of food allergy.
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